# mCRPC lncRNA analysis

Citation: in progress

This project characterizes the lncRNA landscape in mCRPC through an integrative genomics approach. All of the scripts used for analysis are available here in the "src" directory as R notebooks and organized according to figures in the manuscript. Datasets used for this study can be obtained from the following studies:

**scRNA-seq:**

    He MX, Cuoco MS, Crowdis J, et al. Transcriptional mediators of treatment resistance in lethal prostate cancer. Nat Med. (18). doi:10.1038/s41591-021-01244-6

    Kfoury Y, Baryawno N, Severe N, et al. Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Cancer Cell. Published online October 15, 2021. doi:10.1016/J.CCELL.2021.09.005

    Chen S, Zhu G, Yang Y, et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol. 2021;23(1):87-98. doi:10.1038/s41556-020-00613-6

    Song H, Weinstein HNW, Allegakoen P, et al. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. Nat Commun. 2022;13(1). doi:10.1038/s41467-021-27322-4

**WGS:**

    Quigley DA, Dang HX, Zhao SG, Maher CA, Small EJ, Feng FY. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. Cell. 2018;174:758-769. doi:10.1016/j.cell.2018.06.039

    Abida W, Cyrta J, Heller G, et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc Natl Acad Sci U S A. 2019;166(23):11428-11436. doi:10.1073/pnas.1902651116

**WGBS:**

    Zhao SG, Chen WS, Li H, et al. The DNA methylation landscape of advanced prostate cancer. Nat Genet. 2020;52(8):778-789. doi:10.1038/s41588-020-0648-8

**Survival outcomes:**

    Chen WS, Alshalalfa M, Zhao SG, et al. Precision Medicine and Imaging Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types. doi:10.1158/1078-0432.CCR-19-0404

**ChIP-seq:**

    Severson TM, Zhu Y, De Marzo AM, et al. Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases. Mol Oncol. 2021;15(7):1942-1955. doi:10.1002/1878-0261.12923

**RNA-seq:**

    Abeshouse A, Ahn J, Akbani R, et al. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015;163(4):1011-1025. doi:10.1016/j.cell.2015.10.025

    Westbrook TC, Guan X, Rodansky E, et al. Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity. Nat Commun. 2022;13(1):5345. doi:10.1038/s41467-022-32701-6